CLGN SEC Filings: 8-K, 10-Q, S-3 & 424B

Financials

TYPE

HEADLINE

FILED AT

20-F

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]

Mar 26, 2026

20-F

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]

Mar 26, 2025

20-F

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]

Apr 4, 2024

20-F

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]

Mar 29, 2023

20-F

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]

Mar 24, 2022

20-F

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]

Mar 26, 2021

News

TYPE

HEADLINE

FILED AT

6-K

LightSolver Secures ~$1.8 Million Grant from Israel’s Innovation Authority to Advance its Laser Processing Unit (LPU)

Nov 5, 2026

6-K

CollPlant Announces Proposed Name Change to OptiPhi Computing Reflecting Expansion to Computing with Light

Nov 4, 2026

6-K

CollPlant Biotechnologies Calls Extraordinary General Meeting to Vote on Name Change to OptiPhi Computing Ltd.

Nov 3, 2026

6-K

CollPlant Biotechnologies Announces CEO Transition, Cost-Reduction Plan, and Discontinuation of Regenerative Medicine R&D

Nov 2, 2026

6-K

LightSolver Secures Paid Collaboration with Israel Ministry of Defense for Photonic Computing Technology

Oct 29, 2026

6-K

CollPlant Biotechnologies Announces $3.7 Million Private Placement Offering

Oct 15, 2026

Prospectus

TYPE

HEADLINE

FILED AT

424B3

SHARE RESALE REGISTRATION | Shares: 31,047,068 | Bank: H.C. Wainwright & Co., LLC

Jul 17, 2026

424B3

SHARE RESALE REGISTRATION | Shares: 3,296,000 | Bank: H.C. Wainwright & Co., LLC

Apr 21, 2026

424B5

REGISTERED OFFERING

Feb 6, 2026

424B3

Jul 3, 2025

424B5

REGISTERED OFFERING

Jun 2, 2025

424B5

2,000,000 American Depositary Shares Representing 2,000,000 Ordinary Shares-

Feb 16, 2021

Registrations

TYPE

HEADLINE

FILED AT

Form D - Notice of Exempt Offering of Securities - Item 06b

Oct 22, 2026

Form D - Notice of Exempt Offering of Securities - Item 06b

Jul 20, 2026

F-3

SHARE RESALE REGISTRATION

Jul 9, 2026

F-1/A

SHARE RESALE REGISTRATION | Shares: 3,296,000

Apr 15, 2026

F-1

SHARE RESALE REGISTRATION

Mar 30, 2026

Form D - Notice of Exempt Offering of Securities - Item 06b

Feb 17, 2026

Proxies

TYPE

HEADLINE

FILED AT

Ownerships

TYPE

HEADLINE

FILED AT

144

Form 144 - Report of proposed sale of securities

Oct 27, 2026

Shlomi Ruty Ben (Reporting)

Oct 19, 2026

SCHEDULE 13G

Sagy Ami (Filed by)

Oct 8, 2026

SCHEDULE 13D/A

Sagy Ami (Filed by)

Oct 8, 2026

Rotem Eran (Reporting)

Sep 8, 2026

Abelis Bar Berta (Reporting)

Sep 8, 2026

Other

TYPE

HEADLINE

FILED AT

EFFECT

Form EFFECT - Notice of Effectiveness

Jul 17, 2026

EFFECT

Form EFFECT - Notice of Effectiveness

Apr 22, 2026

CORRESP

Form CORRESP - Correspondence

Apr 17, 2026

LETTER

Form UPLOAD - SEC-generated letter

Apr 1, 2026

EFFECT

Form EFFECT - Notice of Effectiveness

Jan 20, 2026

CORRESP

Form CORRESP - Correspondence

Jan 15, 2026

CollPlant Biotechnologies Ltd. CLGN · SEC Filings